Anjelica Gonzalez and Themis Kyriakides elected to AIMBE

Anjelica Gonzalez and Themis Kyriakides have been elected to the American Institute for Medical and Biological Engineering (AIMBE).

Election to the AIMBE College of Fellows is among the highest professional distinctions accorded to a medical and biological engineer and comprises the top 2% of medical and biological engineers. 

Anjelica Gonzalez, associate professor of biomedical engineering, was elected for “pioneering new approaches that merge synthetic biology, protein engineering, and metabolic engineering to achieve novel phenotypes in eukaryotic cells.” 

Themis Kyriakides, associate professor of pathology & biomedical engineering, was elected for “outstanding contributions to the understanding of biomaterial-tissue interactions and advancement of the field of regenerative medicine.”

Jay Humphrey, John C. Malone Professor and Chair of Biomedical Engineering, stated that "the very well-deserved elections of Professors Gonzalez and Kyriakides are appropriate recognitions of their tremendous contributions to the field and an honor for our department."

Due to concerns about COVID-19, Gonzalez and Kyriakides were remotely inducted under special procedures along with 156 colleagues who make up the AIMBE College of Fellows Class of 2020.

College membership honors those who have made outstanding contributions to engineering and medicine research, practice, or education and to the pioneering of new and developing fields of technology, making major advancements in traditional fields of medical and biological engineering, or developing/implementing innovative approaches to bioengineering education.

AIMBE is an advocate for the value of medical and biological engineering to society. Its mission is to recognize excellence, advance the public understanding, and accelerate medical and biological innovation. While most AIMBE Fellows hail from the United States, the College of Fellows has inducted Fellows representing 30 countries. AIMBE Fellows are employed in academia, industry, clinical practice and government.